by AnTolRx | Feb 24, 2020 | Updates
We are excited to announce that we will be presenting at the 3rd Antigen-Specific Immune Tolerance Drug Development conference. We will be discussing AnTolRx’s antigen-specific nanoformulation platform for the treatment of autoimmune diseases! Come join us in... by AnTolRx | Dec 4, 2019 | Updates
We are excited to attend the 38th annual J.P. Morgan Healthcare Conference in San Francisco, CA on January 13th through the 16th. by AnTolRx | Nov 18, 2019 | Updates
We will be attending the symposium “New Frontiers in Therapies for Celiac Disease”. Join us at the University of Chicago (Chicago, IL) on November 23, 2019. by AnTolRx | Oct 29, 2019 | Updates
Psoriasis is an autoimmune disease that affects over 125 million people worldwide, that is up to 3% of the total population! At AnTolRx, our targeted approach actively promotes immune tolerance by inducing an anti-inflammatory phenotype and thus better treat disease.... by AnTolRx | Oct 2, 2019 | Updates
We will be presenting data on AnTolRx’s antigen-specific nanoformulation platform. Join us in Woods Hole, MA, on October 12-13th, 2019. http://www.newenglandimmunology.org by AnTolRx | Mar 1, 2019 | Updates
Dr. Sara Tezza will be presenting data on AnTolRx’s antigen-specific nanoformulation platform. Join us in Boston March 26-28, 2019. http://as-immunetolerance.com